Advertisement
  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami

  • Genetic Testing Gaps

    Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

    by Kate Yandell

  • Expanding Immunotherapy

    At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people.

    by Kevin McLaughlin

  • Should All Kids With Cancer Get Genetic Testing?

    Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

    by Marcus A. Banks

  • Understanding How Radiation Causes Cancer

    Researchers are investigating who is at greatest risk for radiation-induced cancers.

    by Kate Yandell

  • How Long Do Immunotherapy Side Effects Last?

    For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

    by Anna Goshua

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Searching the Blood for Signs of Altered Immunity

    The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

    by Kate Yandell

  • Cancer Care’s Virtual Revolution

    The pandemic has made telehealth a necessity for many cancer patients. When the crisis clears, these technological tools may improve cancer care in the long term.

    by Stephen Ornes

  • From the Editor-in-Chief

    Cancer in Adolescents and Young Adults

    Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.

    by William G. Nelson, MD, PhD

Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR